The new frontier of genome engineering with CRISPR-Cas9
The DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.
Abstract
The advent of facile genome engineering using the bacterial RNA-guided CRISPR-Cas9 system in animals and plants is transforming biology. We review the history of CRISPR (clustered regularly interspaced palindromic repeat) biology from its initial discovery through the elucidation of the CRISPR-Cas9 enzyme mechanism, which has set the stage for remarkable developments using this technology to modify, regulate, or mark genomic loci in a wide variety of cells and organisms from all three domains of life. These results highlight a new era in which genomic manipulation is no longer a bottleneck to experiments, paving the way toward fundamental discoveries in biology, with applications in all branches of biotechnology, as well as strategies for human therapeutics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Repurposing bacterial “CRISPR” systems to facilitate RNA-guided cleavage of complementary DNA has revolutionized the field of gene editing in mammalian cells 1–4.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [3]
In the citing paper
“The CRISPR/Cas9 genome-editing system provides us an unprecedented opportunity to target and modify genomic sequences with high levels of efficacy and specificity [151,152,153,154,155].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [152]
In the citing paper
“gene-editing techniques such as CRISPR-Cas9 [11], have led to a “democratization” of molecular biology, with functional and genomic analyses now possible in a wide range of species”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“This outlook has changed dramatically in the last few years due to the introduction of novel methods that can be directly applied to a wide variety of species.”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“Cas9:sgRNA recognizes the protospacer-adjacent motif (PAM) sequence and a complementary 20-nucleotide genomic sequence and induces double-strand DNA breaks, which are repaired by error-prone nonhomologous end-joining (NHEJ) or precise homology-directed repair (HDR)2,5.”
From Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo (2016) · cites this paper as [2]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · cited 5×
“Targeting with multiple sgRNAs—referred to as multiplexing—was also successfully achieved (75, 86).”
InfluentialCRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947 · cited 3×
“provided the first experimental evidence of CRISPRCas–mediated adaptive immunity (45).”
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762 · cited 2×
“Manyoftheseapplicationshavebeendiscussedinre-centreviews( 91 – 93 ).”
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234 · cited 1×
“This approach was also used to identify genes essential for cell viability in cancer and pluripotent stem cells (102).”
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016 · cited 1×
“coli, whole-genome sequencing showed that there were no detectable off-target effects (127).”
Self-citationDNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696 · cited 1×
“Specifically, fusion of dCas9 to effector domains including VP64 or KRAB allowed stable and efficient transcriptional activation or repression, respectively, in human and yeast cells (129).”
Self-citationWang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Cited by
Items 301–400 of 1,072
Current state and future prospects of pure mycelium materials
Vandelook, S., Elsacker, E., Van Wylick, A., De Laet, L., & Peeters, E. (2021) · Fungal Biology and Biotechnology · doi:10.1186/s40694-021-00128-1 · Cited by 195
“A recent leap forward in targeted genetic modification was made possible with the development of CRISPR/Cas9 as a versatile genetic engineering tool [65, 66].”
BackgroundThe role of genetically engineered pigs in xenotransplantation research
Cooper, D. K., Ekser, B., Ramsoondar, J., Phelps, C., & Ayares, D. (2016) · The Journal of Pathology · doi:10.1002/path.4635 · Cited by 219
Harnessing Type I and Type III CRISPR-Cas systems for genome editing
Li, Y., Pan, S., Zhang, Y., Ren, M., Feng, M., Peng, N., Chen, L., Liang, Y. X., & She, Q. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1044 · Cited by 224
Mao, Y., Zhang, Z., Feng, Z., Wei, P., Zhang, H., Botella, J. R., & Zhu, J. (2016) · Plant Biotechnology Journal · doi:10.1111/pbi.12468 · Cited by 219
“So far, this flexible endonuclease system has been used in many species, including various plants, to generate targeted gene modifications (Brooks et al., 2014; Doudna and Charpentier, 2014; Fauser et al., 2014; Feng et al., 2013; Hsu et al., 2014; Jia and Wang, 2014; Jiang et al., 2013; Mao et al., 2013; Nekrasov et…”
CRISPR versus GMOs: Public acceptance and valuation
Shew, A. M., Nalley, L. L., Snell, H. A., Nayga, R. M., & Dixon, B. L. (2018) · Global Food Security · doi:10.1016/j.gfs.2018.10.005 · Cited by 208
Vitamin E in Plants: Biosynthesis, Transport, and Function
Muñoz, P., & Munné-Bosch, S. (2019) · Trends in Plant Science · doi:10.1016/j.tplants.2019.08.006 · Cited by 215
Liu, H., Wei, Z., Dominguez, A., Li, Y., Wang, X., & Qi, L. S. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv423 · Cited by 211
“…to search for genome-wide sgRNA binding sites and evaluates their efficiency and specificity using a set of rules summarized from published data for CRISPR editing, repression and activation (Cong et al., 2013; Doudna and Charpentier, 2014; Gilbert et al., 2014; Qi et al., 2013; Ran et al., 2013).”
BackgroundMethodBiological plasticity rescues target activity in CRISPR knock outs
Smits, A. H., Ziebell, F., Joberty, G., Zinn, N., Mueller, W. F., Clauder-Münster, S., Eberhard, D., Fälth Savitski, M., Grandi, P., Jakob, P., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0614-5 · Cited by 219
CRISPR-Cas9-based mutagenesis frequently provokes on-target mRNA misregulation
Tuladhar, R., Yeu, Y., Tyler Piazza, J., Tan, Z., Rene Clemenceau, J., Wu, X., Barrett, Q., Herbert, J., Mathews, D. H., Kim, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12028-5 · Cited by 219
Aptazyme-embedded guide RNAs enable ligand-responsive genome editing and transcriptional activation
Tang, W., Hu, J. H., & Liu, D. R. (2017) · Nature Communications · doi:10.1038/ncomms15939 · Cited by 218
Molecular Mechanisms of CRISPR-Cas Immunity in Bacteria
Nussenzweig, P. M., & Marraffini, L. A. (2020) · Annual Review of Genetics · doi:10.1146/annurev-genet-022120-112523 · Cited by 214
Mikuni, T., Nishiyama, J., Sun, Y., Kamasawa, N., & Yasuda, R. (2016) · Cell · doi:10.1016/j.cell.2016.04.044 · Cited by 214
The CRISPR Spacer Space Is Dominated by Sequences from Species-Specific Mobilomes
Shmakov, S. A., Sitnik, V., Makarova, K. S., Wolf, Y. I., Severinov, K. V., & Koonin, E. V. (2017) · mBio · doi:10.1128/mbio.01397-17 · Cited by 217
Nishiyama, J., Mikuni, T., & Yasuda, R. (2017) · Neuron · doi:10.1016/j.neuron.2017.10.004 · Cited by 215
Schiroli, G., Ferrari, S., Conway, A., Jacob, A., Capo, V., Albano, L., Plati, T., Castiello, M. C., Sanvito, F., Gennery, A. R., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan0820 · Cited by 214
“It exploits artificial nucleases, such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and RNA-based CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated protein 9) nucleases, to target a DNA double-strand break (DSB) or nick into a prede…”
BackgroundCRISPR-Cas9 ribonucleoprotein-mediated co-editing and counterselection in the rice blast fungus
Foster, A. J., Martin-Urdiroz, M., Yan, X., Wright, H. S., Soanes, D. M., & Talbot, N. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-32702-w · Cited by 210
Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study
Kaminski, R., Bella, R., Yin, C., Otte, J., Ferrante, P., Gendelman, H. E., Li, H., Booze, R., Gordon, J., Hu, W., et al. (2016) · Gene Therapy · doi:10.1038/gt.2016.41 · Cited by 203
Madzak, C. (2021) · Journal of Fungi · doi:10.3390/jof7070548 · Cited by 189
Epigenome Editing: State of the Art, Concepts, and Perspectives
Kungulovski, G., & Jeltsch, A. (2016) · Trends in Genetics · doi:10.1016/j.tig.2015.12.001 · Cited by 208
“The Concept of Epigenome Editing In genome editing, the designed DNA recognition domains are fused to nuclease domains that induce predetermined changes in the DNA sequence at their target sites [24,25].”
BackgroundOn the Origin of CRISPR-Cas Technology: From Prokaryotes to Mammals
Mojica, F. J. M., & Montoliu, L. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.06.005 · Cited by 189
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates
Liu, X.-M., Zhou, J., Mao, Y., Ji, Q., & Qian, S.-B. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0327-1 · Cited by 208
Synthetic Biology—The Synthesis of Biology
Ausländer, S., Ausländer, D., & Fussenegger, M. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201609229 · Cited by 206
Organoids for Drug Discovery and Personalized Medicine
Takahashi, T. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021108 · Cited by 199
Zhang, M., Wang, H., Wang, H., Wang, F., & Li, Z. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c00686 · Cited by 213
The Revolution Continues: Newly Discovered Systems Expand the CRISPR-Cas Toolkit
Murugan, K., Babu, K., Sundaresan, R., Rajan, R., & Sashital, D. G. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.007 · Cited by 205
“Cas9 has been used extensively for genome editing in a huge variety of organisms (Doudna and Charpentier, 2014; Hsu et al., 2014).”
BackgroundA semisynthetic organism engineered for the stable expansion of the genetic alphabet
Zhang, Y., Lamb, B. M., Feldman, A. W., Zhou, A. X., Lavergne, T., Li, L., & Romesberg, F. E. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616443114 · Cited by 203
“In type II CRISPR-Cas systems, such as that from Streptococcus pyogenes (21, 22), the endonuclease Cas9 uses encoded RNAs [or their artificial mimics known as single-guide RNAs (sgRNAs) (23)] to introduce double-strand breaks in cDNA upstream of a 5′-NGG-3′ protospacer adjacent motif (PAM) (24), which then results in…”
BackgroundChoose and Use Your Chemical Probe Wisely to Explore Cancer Biology
Blagg, J., & Workman, P. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.06.005 · Cited by 203
“10 Cancer Cell 32, July 10, 2017 Although small-molecule and biological tool approaches are two different worlds in the same universe, it is interesting to see that these worlds are now converging with the advent, on the one hand, of specificprotein functionmodulation throughCRISPR gene-editing technology (Doudna and…”
BackgroundHaverkamp, A., Hansson, B. S., & Knaden, M. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00049 · Cited by 186
“As with CRISPR/Cas9 (Doudna and Charpentier, 2014) finally molecular tools have emerged that e.”
BackgroundNanoBRET: The Bright Future of Proximity-Based Assays
Dale, N. C., Johnstone, E. K. M., White, C. W., & Pfleger, K. D. G. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00056 · Cited by 182
“…use of CRISPR to perform a BRET assay was reported by White et al. (2017), where successful observation of a BRET signal was achieved using proteins expressed under endogenous promotion tagged with Nluc through the use of CRISPR/Cas9-mediated homologydirected repair (Doudna and Charpentier, 2014).”
MethodGenome Editing in Rice: Recent Advances, Challenges, and Future Implications
Mishra, R., Joshi, R. K., & Zhao, K. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.01361 · Cited by 200
“The CRISPR/Cas9 and its modified versions have wide applications in animals, plants, yeast, and human as well as in non-human cell lines (Doudna and Charpentier, 2014; Khatodia et al., 2016; Miglani, 2017).”
BackgroundCRISPR-Cas9-Mediated Genome Editing in Leishmania donovani
Zhang, W.-W., & Matlashewski, G. (2015) · mBio · doi:10.1128/mbio.00861-15 · Cited by 195
Vaccines against pseudorabies virus (PrV)
Freuling, C. M., Müller, T. F., & Mettenleiter, T. C. (2017) · Veterinary Microbiology · doi:10.1016/j.vetmic.2016.11.019 · Cited by 204
Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia
Lim, J. S., Gopalappa, R., Kim, S. H., Ramakrishna, S., Lee, M., Kim, W.-I., Kim, J., Park, S. M., Lee, J., Oh, J.-H., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.01.030 · Cited by 207
“The American Journal of Human G CRISPR (clustered regularly interspaced short palindromic repeats)Cas9 (CRISPR-associated protein 9) system is becoming widely used to efficiently and accurately edit the genome in vitro and in vivo.(23) We and other groups have also used the CRISPR-Cas9 system to edit the genome in cul…”
CRISPR/dC as9 platforms in plants: strategies and applications beyond genome editing
Moradpour, M., & Abdulah, S. N. A. (2020) · Plant Biotechnology Journal · doi:10.1111/pbi.13232 · Cited by 193
Cell-based therapy technology classifications and translational challenges
Mount, N. M., Ward, S. J., Kefalas, P., & Hyllner, J. (2015) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0017 · Cited by 195
Nucleosomes inhibit target cleavage by CRISPR-Cas9 in vivo
Yarrington, R. M., Verma, S., Schwartz, S., Trautman, J. K., & Carroll, D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810062115 · Cited by 194
Lactic Acid Bacteria in Wine: Technological Advances and Evaluation of Their Functional Role
Virdis, C., Sumby, K., Bartowsky, E., & Jiranek, V. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.612118 · Cited by 184
“This strategy exploits the functions of CRISPR and CRISPR-associated genes (Doudna and Charpentier, 2014; van Pijkeren and Barrangou, 2017).”
BackgroundStructural Plasticity of PAM Recognition by Engineered Variants of the RNA-Guided Endonuclease Cas9
Anders, C., Bargsten, K., & Jinek, M. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.020 · Cited by 201
“In recent years, Cas9 nucleases have been repurposed to develop a transformative genome editing technology (Doudna and Charpentier, 2014).”
BackgroundEfficient oligo nucleotide mediated CRISPR-Cas9 gene editing in Aspergilli
Nødvig, C. S., Hoof, J. B., Kogle, M. E., Jarczynska, Z. D., Lehmbeck, J., Klitgaard, D. K., & Mortensen, U. H. (2018) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2018.01.004 · Cited by 197
Cecchini, C., Pannilunghi, S., Tardy, S., & Scapozza, L. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.672267 · Cited by 193
“In parallel, the recent advent of CRISPR–Cas9 technology offers the possibility of in situ genome editing to achieve gene knockout (Doudna and Charpentier, 2014).”
BackgroundCRISPR-Cas9: a new and promising player in gene therapy
Xiao-Jie, L., Hui-Ying, X., Zun-Ping, K., Jin-Lian, C., & Li-Juan, J. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102968 · Cited by 200
Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch
Oakes, B. L., Nadler, D. C., Flamholz, A., Fellmann, C., Staahl, B. T., Doudna, J. A., & Savage, D. F. (2016) · Nature Biotechnology · doi:10.1038/nbt.3528 · Cited by 200
“For example, an allosterically regulated Cas9 would permit conditional control of activity and allow precise interrogation of development, disease progression and differentiation 5,6,13,14 .”
Self-citationProgress and Prospects of CRISPR/Cas Systems in Insects and Other Arthropods
Sun, D., Guo, Z., Liu, Y., & Zhang, Y. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00608 · Cited by 190
“…the protein, both of which can cleave exogenous double-stranded DNA (dsDNA) (Figure 1D), the HNH nuclease domain cleaves the DNA strand that is complementary to the crRNA; the RuvClike nuclease domain of Cas9 cleaves the DNA strand opposite the complementary strand (Doudna and Charpentier, 2014).”
BackgroundWeb-based design and analysis tools for CRISPR base editing
Hwang, G.-H., Park, J., Lim, K., Kim, S., Yu, J., Yu, E., Kim, S.-T., Eils, R., Kim, J.-S., & Bae, S. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2585-4 · Cited by 198
Engineering of high-precision base editors for site-specific single nucleotide replacement
Tan, J., Zhang, F., Karcher, D., & Bock, R. (2019) · Nature Communications · doi:10.1038/s41467-018-08034-8 · Cited by 186
The importance of genomic variation for biodiversity, ecosystems and people
Stange, M., Barrett, R. D. H., & Hendry, A. P. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-020-00288-7 · Cited by 190
Chronic Granulomatous Disease: a Comprehensive Review
Yu, H.-H., Yang, Y.-H., & Chiang, B.-L. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08800-x · Cited by 197
“CRISPR/Cas9 nucleases, guided by a designed single-guide RNA complementary to the target site of interest, can achieve efficient DSB, which undergo repair by non-homologous end joining (NHEJ) causing insertions or deletions or by homology-directed repair (HDR) allowing donor DNA incorporation [87].”
BackgroundStrategies for nonviral nanoparticle‐based delivery of CRISPR/Cas9 therapeutics
Chen, F., Alphonse, M., & Liu, Q. (2020) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1609 · Cited by 197
CRISPaint allows modular base-specific gene tagging using a ligase-4-dependent mechanism
Schmid-Burgk, J. L., Höning, K., Ebert, T. S., & Hornung, V. (2016) · Nature Communications · doi:10.1038/ncomms12338 · Cited by 193
RNA-based recognition and targeting: sowing the seeds of specificity
Gorski, S. A., Vogel, J., & Doudna, J. A. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.174 · Cited by 190
Self-citationZhou, W., Cui, H., Ying, L., & Yu, X. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201806941 · Cited by 195
Singh, D., Mallon, J., Poddar, A., Wang, Y., Tippana, R., Yang, O., Bailey, S., & Ha, T. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718686115 · Cited by 199
Developing algae as a sustainable food source
Diaz, C. J., Douglas, K. J., Kang, K., Kolarik, A. L., Malinovski, R., Torres-Tiji, Y., Molino, J. V., Badary, A., & Mayfield, S. P. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1029841 · Cited by 194
Noncoding RNAs: Master Regulators of Inflammatory Signaling
Chew, C. L., Conos, S. A., Unal, B., & Tergaonkar, V. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.11.003 · Cited by 195
CRISPR/Cas9 genome editing technology in filamentous fungi: progress and perspective
Song, R., Zhai, Q., Sun, L., Huang, E., Zhang, Y., Zhu, Y., Guo, Q., Tian, Y., Zhao, B., & Lu, H. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10007-w · Cited by 185
Visualizing transcription factor dynamics in living cells
Liu, Z., & Tjian, R. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201710038 · Cited by 186
“Encouragingly, the rapid development of genome-editing techniques (Doudna and Charpentier, 2014) enabled functional labeling and imaging of endogenous proteins as reported in several recent studies (Teves et al.”
Hautbergue, T., Jamin, E. L., Debrauwer, L., Puel, O., & Oswald, I. P. (2018) · Natural Product Reports · doi:10.1039/c7np00032d · Cited by 185
Prielhofer, R., Barrero, J. J., Steuer, S., Gassler, T., Zahrl, R., Baumann, K., Sauer, M., Mattanovich, D., Gasser, B., & Marx, H. (2017) · BMC Systems Biology · doi:10.1186/s12918-017-0492-3 · Cited by 188
“Transcription units for sgRNA (fusion of crRNA and tracrRNA [42]) and”
A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9
Carroll, K. J., Makarewich, C. A., McAnally, J., Anderson, D. M., Zentilin, L., Liu, N., Giacca, M., Bassel-Duby, R., & Olson, E. N. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523918113 · Cited by 185
“The recent identification of the clustered regularly interspaced short palindromic repeats (CRISPR)-associated (Cas)9 system has revolutionized the field of genetics and has greatly facilitated the generation of genetically modified animals (2).”
BackgroundThe importance of thiamine (vitamin B1) in plant health: From crop yield to biofortification
Fitzpatrick, T. B., & Chapman, L. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.010918 · Cited by 177
“However, the introduction of CRISPR/Cas9 technologies for genetic engineering (108) has enabled targeted insertion of transgenes at specific locations throughout plant genomes (11, 13) and without additional insertion of bacterial flanking DNA (109).”
BackgroundChen, B., Hu, J., Almeida, R., Liu, H., Balakrishnan, S., Covill-Cooke, C., Lim, W. A., & Huang, B. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1533 · Cited by 186
Development of Light‐Activated CRISPR Using Guide RNAs with Photocleavable Protectors
Jain, P. K., Ramanan, V., Schepers, A. G., Dalvie, N. S., Panda, A., Fleming, H. E., & Bhatia, S. N. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201606123 · Cited by 191
CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion
Mou, H., Smith, J. L., Peng, L., Yin, H., Moore, J., Zhang, X.-O., Song, C.-Q., Sheel, A., Wu, Q., Ozata, D. M., et al. (2017) · Genome Biology · doi:10.1186/s13059-017-1237-8 · Cited by 177
“CRISPR therefore provides a simple way to generate loss-offunction (LOF) mutations in virtually any gene in the mammalian genome [1].”
BackgroundEvolutionary dynamics of CRISPR gene drives
Noble, C., Olejarz, J., Esvelt, K. M., Church, G. M., & Nowak, M. A. (2017) · Science Advances · doi:10.1126/sciadv.1601964 · Cited by 192
Zhang, Y., Qian, L., Wei, W., Wang, Y., Wang, B., Lin, P., Liu, W., Xu, L., Li, X., Liu, D., et al. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00215 · Cited by 189
Lemos, B. R., Kaplan, A. C., Bae, J. E., Ferrazzoli, A. E., Kuo, J., Anand, R. P., Waterman, D. P., & Haber, J. E. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716855115 · Cited by 185
“Specificity is achieved by a Cas9-bound guide RNA (gRNA) that pairs with sequences adjacent to the PAM, resulting in double-strand DNA cleavage 3-bp 5′ of the PAM sequence (7).”
BackgroundDevelopment of CRISPR-Cas systems for genome editing and beyond
Zhang, F. (2019) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583519000052 · Cited by 181
“In addition to this perspective, there are a number of general reviews covering this topic (Doudna and Charpentier, 2014; Hsu et al., 2014; van der Oost et al., 2014; Marraffini, 2015; Sontheimer and Barrangou, 2015; Mojica and Rodriguez-Valera, 2016; Barrangou and Horvath, 2017; Koonin and…”
BackgroundBothmer, A., Phadke, T., Barrera, L. A., Margulies, C. M., Lee, C. S., Buquicchio, F., Moss, S., Abdulkerim, H. S., Selleck, W., Jayaram, H., et al. (2017) · Nature Communications · doi:10.1038/ncomms13905 · Cited by 187
Heritable genome editing with CRISPR/Cas9 induces anosmia in a crop pest moth
Koutroumpa, F. A., Monsempes, C., François, M.-C., de Cian, A., Royer, C., Concordet, J.-P., & Jacquin-Joly, E. (2016) · Scientific Reports · doi:10.1038/srep29620 · Cited by 179
Genome editing in plants by engineered CRISPR–Cas9 recognizing NG PAM
Endo, M., Mikami, M., Endo, A., Kaya, H., Itoh, T., Nishimasu, H., Nureki, O., & Toki, S. (2018) · Nature Plants · doi:10.1038/s41477-018-0321-8 · Cited by 185
Hasnain, A., Naqvi, S. A. H., Ayesha, S. I., Khalid, F., Ellahi, M., Iqbal, S., Hassan, M. Z., Abbas, A., Adamski, R., Markowska, D., et al. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.1009395 · Cited by 218
“Using this technical approach, new plant kinds can be created without the input of foreign genes (Doudna and Charpentier 2014; Baltes and Voytas 2015; Nogueira et al., 2018).”
BackgroundOff-target predictions in CRISPR-Cas9 gene editing using deep learning
Lin, J., & Wong, K.-C. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty554 · Cited by 185
“Moreover, CRISPR can help us analyse the genetic interactions and the relationships between genetic variations and phenotypes (Cox et al., 2015; Doudna and Charpentier, 2014; Hsu et al., 2014; Shapiro et al., 2018; Shen et al., 2017; Smith et al., 2015).”
BackgroundCRISPy-web: An online resource to design sgRNAs for CRISPR applications
Blin, K., Pedersen, L. E., Weber, T., & Lee, S. Y. (2016) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2016.01.003 · Cited by 190
Genome editing of crops: A renewed opportunity for food security
Georges, F., & Ray, H. (2017) · GM Crops & Food · doi:10.1080/21645698.2016.1270489 · Cited by 173
“Details of the functioning mechanism of the CRISPR/Cas9 system have now been described many times (Hsu et al., 2014; Doudna & Charpentier, 2014).”
MethodLi, F., Xie, G., Huang, J., Zhang, R., Li, Y., Zhang, M., Wang, Y., Li, A., Li, X., Xia, T., et al. (2017) · Plant Biotechnology Journal · doi:10.1111/pbi.12700 · Cited by 180
“As recent CRISPR/Cas9 technology is well developed (Doudna and Charpentier, 2014), it could be applied to generate a bunch of mutants from other conserved-site mutations in three CESA4/7/9 isoforms, which may lead to finding out optimal mutants in rice and beyond.”
BackgroundChen, Z., Wu, C., Yuan, Y., Xie, Z., Li, T., Huang, H., Li, S., Deng, J., Lin, H., Shi, Z., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01903-5 · Cited by 182
CRISPR-Cas9 conformational activation as elucidated from enhanced molecular simulations
Palermo, G., Miao, Y., Walker, R. C., Jinek, M., & McCammon, J. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707645114 · Cited by 172
Fluorescent nanodiamonds: past, present, and future
Alkahtani, M. H., Alghannam, F., Jiang, L., Almethen, A., Rampersaud, A. A., Brick, R., Gomes, C. L., Scully, M. O., & Hemmer, P. R. (2018) · Nanophotonics · doi:10.1515/nanoph-2018-0025 · Cited by 180
Editing of the urease gene by CRISPR-Cas in the diatom Thalassiosira pseudonana
Hopes, A., Nekrasov, V., Kamoun, S., & Mock, T. (2016) · Plant Methods · doi:10.1186/s13007-016-0148-0 · Cited by 175
Fu, Y.-W., Dai, X.-Y., Wang, W.-T., Yang, Z.-X., Zhao, J.-J., Zhang, J.-P., Wen, W., Zhang, F., Oberg, K. C., Zhang, L., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1251 · Cited by 180
“CRISPR–Cas9 mediated DSB has been reported to be blunt with error-prone DNA repair systems generating random and unpredictable mutations (29).”
BackgroundMultidimensional chemical control of CRISPR–Cas9
Maji, B., Moore, C. L., Zetsche, B., Volz, S. E., Zhang, F., Shoulders, M. D., & Choudhary, A. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2224 · Cited by 177
Applications of CRISPR/Cas System to Bacterial Metabolic Engineering
Cho, S., Shin, J., & Cho, B.-K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041089 · Cited by 169
“Its simple and highly specific cleavage at the target sequence has yielded significant advancements in the development of versatile tools for editing and manipulating genomes in various organisms [15,16].”
BackgroundGuan, Y., Ma, Y., Li, Q., Sun, Z., Ma, L., Wu, L., Wang, L., Zeng, L., Shao, Y., Chen, Y., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201506039 · Cited by 178
“…adaptive immune system identified in bacteria is a revolutionary technology for gene editing in cells and organisms (Jinek et al, 2012; Cong et al, 2013; Hwang et al, 2013; Li et al, 2013; Mali et al, 2013; Shen et al, 2013; Wang et al, 2013; Doudna & Charpentier, 2014; Niu et al, 2014).”
BackgroundCellular processing and destinies of artificial DNA nanostructures
Lee, D. S., Qian, H., Tay, C. Y., & Leong, D. T. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00700c · Cited by 176
Bahal, R., Ali McNeer, N., Quijano, E., Liu, Y., Sulkowski, P., Turchick, A., Lu, Y.-C., Bhunia, D. C., Manna, A., Greiner, D. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms13304 · Cited by 182
Deciphering, Communicating, and Engineering the CRISPR PAM
Leenay, R. T., & Beisel, C. L. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.11.024 · Cited by 180
MACBETH: Multiplex automated Corynebacterium glutamicum base editing method
Wang, Y., Liu, Y., Liu, J., Guo, Y., Fan, L., Ni, X., Zheng, X., Wang, M., Zheng, P., Sun, J., et al. (2018) · Metabolic Engineering · doi:10.1016/j.ymben.2018.02.016 · Cited by 179
DNA-based memory devices for recording cellular events
Sheth, R. U., & Wang, H. H. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0052-8 · Cited by 172
Aptamer functionalized nanomaterials for biomedical applications: Recent advances and new horizons
Mahmoudpour, M., Ding, S., Lyu, Z., Ebrahimi, G., Du, D., Ezzati Nazhad Dolatabadi, J., Torbati, M., & Lin, Y. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101177 · Cited by 177
Ordon, J., Gantner, J., Kemna, J., Schwalgun, L., Reschke, M., Streubel, J., Boch, J., & Stuttmann, J. (2017) · The Plant Journal · doi:10.1111/tpj.13319 · Cited by 174
Spit, J., Philips, A., Wynant, N., Santos, D., Plaetinck, G., & Vanden Broeck, J. (2017) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2017.01.004 · Cited by 176
Development of a CRISPR/Cas9-based therapy for Hutchinson–Gilford progeria syndrome
Santiago-Fernández, O., Osorio, F. G., Quesada, V., Rodríguez, F., Basso, S., Maeso, D., Rolas, L., Barkaway, A., Nourshargh, S., Folgueras, A. R., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0338-6 · Cited by 175
Hacisalihoglu, G. (2020) · Plants · doi:10.3390/plants9111471 · Cited by 165
“There is a need for more research and some of the suggested research approaches to further explore Zn efficiency may include the following: (1) Identifying the target genes and pathways for Zn efficiency in plants; (2) investigating potential genome editing technologies (CRISPR-Cas9) [64]; (3) developing new methods t…”
BackgroundLafora disease — from pathogenesis to treatment strategies
Nitschke, F., Ahonen, S. J., Nitschke, S., Mitra, S., & Minassian, B. A. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0057-0 · Cited by 167
RNA Nanotechnology-Mediated Cancer Immunotherapy
Lin, Y.-X., Wang, Y., Blake, S., Yu, M., Mei, L., Wang, H., & Shi, J. (2020) · Theranostics · doi:10.7150/thno.35568 · Cited by 169
“CRISPR/Cas9 system (clustered regularly interspaced short palindromic repeats) [178], is an RNA-guided DNA targeting technology, which has been widely applied to genome editing [180, 181], gene therapy [182] and manipulation of induced pluripotent stem cells (iPS) studies[183].”
BackgroundEngineering plant architecture via CRISPR/Cas9-mediated alteration of strigolactone biosynthesis
Butt, H., Jamil, M., Wang, J. Y., Al-Babili, S., & Mahfouz, M. (2018) · BMC Plant Biology · doi:10.1186/s12870-018-1387-1 · Cited by 164
Genetic basis and adaptation trajectory of soybean from its temperate origin to tropics
Dong, L., Fang, C., Cheng, Q., Su, T., Kou, K., Kong, L., Zhang, C., Li, H., Hou, Z., Zhang, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25800-3 · Cited by 166
Goshisht, M. K. (2024) · ACS Omega · doi:10.1021/acsomega.3c05913 · Cited by 161
Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference
Barrangou, R., Birmingham, A., Wiemann, S., Beijersbergen, R. L., Hornung, V., & Smith, A. V. B. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv226 · Cited by 165
Mobile Genetic Elements and Evolution of CRISPR-Cas Systems: All the Way There and Back
Koonin, E. V., & Makarova, K. S. (2017) · Genome Biology and Evolution · doi:10.1093/gbe/evx192 · Cited by 176
“…(Cas) systems and individual Cas proteins have been explored with an unprecedented intensity (Sorek et al. 2013; Barrangou and Marraffini 2014; Doudna and Charpentier 2014; Hsu et al. 2014; Mohanraju et al. 2016; Wright et al. 2016; Barrangou and Horvath 2017; Komor et al. 2017; Koonin et al.…”
Background
Metadata
- Authors
- Doudna, J. A., & Charpentier, E.
- Affiliations
- Howard Hughes Medical Institute (US)
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Doudna, Jennifer A.
- Charpentier, Emmanuelle
- Venue
- Science
- Published
- 2014-11-28
- Volume
- 346
- Issue
- 6213
- Pages
- 1258096-1258096
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2050480410
- Semantic Scholar
- e138728065ae7707ff75c3b6a5a52e81856ccf1b
- Cited by
- 7,062
- References
- 154
- Citations by year
- 2026: 560 · 2025: 716 · 2024: 665 · 2023: 580 · 2022: 689 · 2021: 700 · 2020: 653 · 2019: 578 · 2018: 569 · 2017: 545 · 2016: 471 · 2015: 314 · 2014: 3
- FWCI
- 41.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR/Cas9, genome editing, RNA-guided genome editing, genome modification, genome regulation, biotechnology applications, human therapeutics
- MeSH terms
- Animals, Genetic Engineering, Humans, Genome, Human, Gene Targeting, DNA Cleavage, RNA, Small Untranslated, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.